A woman who has transformed commercialisation of medical research at the University of Edinburgh has been named Knowledge Exchange Hero 2021 in the Scottish Knowledge Exchange Awards.
22 April, 2021
Please join us at the Zoom launch event for Elsevier’s new journal: “Artificial Intelligence in the Life Sciences” Wednesday May 5th 2021 at 3:00pm UK time.
20 April, 2021
First subjects dosed with AKS-452, COVID-19 vaccine candidate in the Netherlands trial the vaccine is shelf-stable for 4 months at 25 degrees Celsius (77° Fahrenheit). 176 volunteers will participate in the clinical trial the safety and immune response read-outs expected in Q2 2021
15 April, 2021
Company’s technologies and drug-hunting expertise now responsible for world’s first and second AI-designed drugs to enter Phase I testing
15 April, 2021
Healx, the AI-powered, patient-inspired technology company accelerating the discovery and development of rare disease treatments at scale, announced that it would be working with Ataxia UK and FARA to develop novel treatments for Friedreich's ataxia - a rare neurodegenerative condition that causes issues with balance, speech and coordination.
08 April, 2021
An £8.7 million, five-year research collaboration led by the University of Edinburgh and FUJIFILM Diosynth Biotechnologies UK (FDB) will develop more cost-effective ways to make modern antibody-based medicines.
07 April, 2021
A palliative care doctor has suggested that studying Shakespeare’s plays could help medical students connect more closely with their patients. Writing in the Journal of the Royal Society of Medicine Dr David Jeffrey, of the Department of Palliative Medicine at the University of Edinburgh, investigates how the playwright’s empathic approach - the ability to understand and share the feelings of another - can enhance the patient-doctor relationship.
02 April, 2021